What Assembly Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 5 |
| Total trades | 0 | 16 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 746,698 |
| Disposed | 0 | 554 |
| Net activity | +0 | +746,144 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | PFO and PAO | Jun 17 | Open-market sale · S | −29 | $23.25 | −$674 | 14,560 |
| Gilead SCIENCES, Inc. | 10% owner | May 26 | Grant / award · A | +471,698 | $26.50 | +$12.5M | 4,977,089 |
| White Nicole S | Chief Manufacturing Officer | Mar 30 | Open-market sale · S | −9 | $27.49 | −$247 | 37,477 |
| White Nicole S | Chief Manufacturing Officer | Mar 30 | Open-market sale · S | −188 | $26.65 | −$5.01K | 37,486 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 30 | Open-market sale · S | −16 | $27.49 | −$440 | 11,089 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 30 | Open-market sale · S | −312 | $26.65 | −$8.31K | 11,105 |
| Okazaki Jason A | CEO and President | Mar 29 | Grant / award · A | +50,750 | — | — | 163,354 |
| Delaney William E Iv | Chief Scientific Officer | Mar 29 | Grant / award · A | +14,000 | — | — | 60,330 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 29 | Grant / award · A | +3,500 | — | — | 14,589 |
| White Nicole S | Chief Manufacturing Officer | Mar 29 | Grant / award · A | +14,000 | — | — | 48,145 |
| Gaggar Anuj | Chief Medical Officer | Mar 29 | Grant / award · A | +14,000 | — | — | 42,688 |
| Okazaki Jason A | CEO and President | Mar 29 | Grant / award · A | +94,250 | — | — | 111,916 |
| Delaney William E Iv | Chief Scientific Officer | Mar 29 | Grant / award · A | +26,000 | — | — | 45,642 |
| Gaggar Anuj | Chief Medical Officer | Mar 29 | Grant / award · A | +26,000 | — | — | 28,000 |
| White Nicole S | Chief Manufacturing Officer | Mar 29 | Grant / award · A | +26,000 | — | — | 37,674 |
| Bjorkquist Jeanette M | PFO and PAO | Mar 29 | Grant / award · A | +6,500 | — | — | 11,417 |
| Gilead SCIENCES, Inc. | 10% owner | Aug 08 | Open-market buy · P | +2,295,920 | — | — | 4,505,391 |
| Bjorkquist Jeanette M | PFO and PAO | Jun 16 | Grant / award · A | +300 | — | — | 5,097 |
| Okazaki Jason A | CEO and President | Mar 31 | Open-market sale · S | −355 | $9.85 | −$3.5K | 14,757 |
| White Nicole S | Chief Manufacturing Officer | Mar 31 | Open-market sale · S | −197 | $9.85 | −$1.94K | 11,674 |
Loading...
